These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25245442)

  • 1. By the numbers: does circulating tumor cell enumeration have a role in metastatic breast cancer?
    Liu MC
    J Clin Oncol; 2014 Nov; 32(31):3479-82. PubMed ID: 25245442
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells and emerging blood biomarkers in breast cancer.
    Criscitiello C; Sotiriou C; Ignatiadis M
    Curr Opin Oncol; 2010 Nov; 22(6):552-8. PubMed ID: 20706122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 expression by circulating breast cancer cells.
    David R
    Lancet Oncol; 2015 Jul; 16(7):e321. PubMed ID: 26095782
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
    Mostert B; Sleijfer S; Foekens JA; Gratama JW
    Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of circulating tumor cells in primary and metastatic breast cancer.
    Aurilio G; Sciandivasci A; Munzone E; Sandri MT; Zorzino L; Cassatella MC; Verri E; Rocca MC; Nolè F
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):203-14. PubMed ID: 22316368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longtime recirculating tumor cells in breast cancer patients.
    Pachmann K
    Clin Cancer Res; 2005 Aug; 11(15):5657; author reply 5657-8. PubMed ID: 16061886
    [No Abstract]   [Full Text] [Related]  

  • 10. Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy".
    Foroni C; Milan M; Strina C; Cappelletti M; Fumarola C; Bonelli M; Bertoni R; Ferrero G; Maldotti M; Takano E; Andreis D; Venturini S; Brugnoli G; Petronini PG; Zanoni V; Pritzker L; Pritzker K; Parissenti A; Santini D; Fox SB; Bottini A; Generali D
    Breast Cancer Res Treat; 2014 Feb; 144(1):113-21. PubMed ID: 24469643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of the detection of circulating tumor cells in breast cancer patients.
    Banys M; Hartkopf AD; Krawczyk N; Becker S; Fehm T
    Biomark Med; 2012 Feb; 6(1):109-18. PubMed ID: 22296204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent translational research: circulating tumor cells in breast cancer patients.
    Müller V; Hayes DF; Pantel K
    Breast Cancer Res; 2006; 8(5):110. PubMed ID: 16953898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating epithelial cells in breast cancer.
    Kunkler IH
    N Engl J Med; 2004 Dec; 351(23):2452-4; author reply 2452-4. PubMed ID: 15580680
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of tumor markers and circulating tumors cells in the management of breast cancer.
    Saad A; Abraham J
    Oncology (Williston Park); 2008 Jun; 22(7):726-31; discussion 734, 739, 743-4. PubMed ID: 18619119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.
    Payne RE; Yagüe E; Slade MJ; Apostolopoulos C; Jiao LR; Ward B; Coombes RC; Stebbing J
    Pharmacogenomics; 2009 Jan; 10(1):51-7. PubMed ID: 19102715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating stem cells: a comparison of breast cancer and cardiovascular pathology].
    Bershteĭn LM
    Vopr Onkol; 2009; 55(5):528-33. PubMed ID: 20020646
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating tumor cells in breast cancer.
    Banys M; Müller V; Melcher C; Aktas B; Kasimir-Bauer S; Hagenbeck C; Hartkopf A; Fehm T
    Clin Chim Acta; 2013 Aug; 423():39-45. PubMed ID: 23623805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients.
    Hauch S; Zimmermann S; Lankiewicz S; Zieglschmid V; Böcher O; Albert WH
    Anticancer Res; 2007; 27(3A):1337-41. PubMed ID: 17593628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 as marker for the detection of circulating tumor cells.
    Müller V; Pantel K
    Breast Cancer Res Treat; 2009 Oct; 117(3):535-7. PubMed ID: 19115105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.